Literature DB >> 30682193

Correction: miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells.

Piyush Gondaliya, Aishwarya Dasare, Akshay Srivastava, Kiran Kalia.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0208044.].

Entities:  

Year:  2019        PMID: 30682193      PMCID: PMC6347208          DOI: 10.1371/journal.pone.0211591

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The images for Figs 6–9 are incorrectly switched. The image that appears as Fig 6 should be Fig 9; the image that appears as Fig 7 should be Fig 6; the image that appears as Fig 8 should be Fig 7; and the image that appears as Fig 9 should be Fig 8. The figure captions appear in the correct order. Please see the correct figures and their respective captions here.
Fig 6

Effect of miR29b mimics and inhibitors on expression profiles of DNMT1 in DN model.

A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT1 expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT1. Scale bar, 20 μm. Representative (n = 5), * indicates ‘p’ value <0.05, **indicates ‘p’ value < 0.01, *** indicate p value <0.001.

Fig 9

miR-29b decreases fibrosis and tubular injury via downregulation of fibronectin and KIM-1.

A and B: Effect of miR29b mimics and inhibitors on expression profiles of KIM-1 and Fibronectin in DN model (n = 2), * indicates p value <0.05.

Fig 7

Effect of miR29b mimics and inhibitors on expression profiles of DNMT3B in DN model.

A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT3B expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT3B. Scale bar, 20 μm. Representative (n = 5), * indicates ‘p’ value <0.05, ** indicates ‘p’ value < 0.01, *** indicate p value <0.001.

Fig 8

Effect of miR-29b mimics and inhibitor on expression profile of DNMT3A in DN model.

A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT3A expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT3A. Scale bar, 18μm. Representative (n = 5), *indicates ‘p’ value <0.05, ** indicates ‘p’ value < 0.01, *** indicate p value <0.001.

Effect of miR29b mimics and inhibitors on expression profiles of DNMT1 in DN model.

A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT1 expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT1. Scale bar, 20 μm. Representative (n = 5), * indicates ‘p’ value <0.05, **indicates ‘p’ value < 0.01, *** indicate p value <0.001.

Effect of miR29b mimics and inhibitors on expression profiles of DNMT3B in DN model.

A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT3B expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT3B. Scale bar, 20 μm. Representative (n = 5), * indicates ‘p’ value <0.05, ** indicates ‘p’ value < 0.01, *** indicate p value <0.001.

Effect of miR-29b mimics and inhibitor on expression profile of DNMT3A in DN model.

A and B: Immunofluorescence microscopy as well as quantitative analysis shows that transfection with miR29b mimics attenuated DNMT3A expression level while transfection with miR29b inhibitors showed elevated expression levels of DNMT3A. Scale bar, 18μm. Representative (n = 5), *indicates ‘p’ value <0.05, ** indicates ‘p’ value < 0.01, *** indicate p value <0.001.

miR-29b decreases fibrosis and tubular injury via downregulation of fibronectin and KIM-1.

A and B: Effect of miR29b mimics and inhibitors on expression profiles of KIM-1 and Fibronectin in DN model (n = 2), * indicates p value <0.05.
  1 in total

1.  miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells.

Authors:  Piyush Gondaliya; Aishwarya Dasare; Akshay Srivastava; Kiran Kalia
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

  1 in total
  1 in total

Review 1.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.